Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07828639

A Study of VC005 Tablets in Adolescent Subjects With Non-Segmental Vitiligo

This study is a multicenter, open-label, non-randomized study designed to evaluate the pharmacokinetics (PK), safety, and preliminary efficacy of VC005 tablets in adolescent subjects with Non-Segmental Vitiligo

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Non-Segmental Vitiligo

Age range

12 year–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1 / Phase 2

Primary location

The Peking University People's Hospital

Beijing, Beijing Municipality, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The subject fully understands this study and is able to comply with the relevant trial procedures. The subject and their legal guardian voluntarily sign the informed consent form (ICF).
  • Age 12 to 18 years inclusive (including 12 years old, excluding 18 years old) at the time of signing the ICF, both genders, with body weight ≥ 30 kg.
  • Subjects with a clinical diagnosis of non-segmental vitiligo

Exclusion criteria

  • Pregnant or breastfeeding women, or subjects planning to become pregnant or breastfeed during the study period.
  • Trial participants with complete depigmentation of hair within the vitiligo area.
  • Trial participants clinically diagnosed with segmental vitiligo, mucosal non-segmental vitiligo, or other cutaneous depigmentation disorders.

Treatment and study plan

VC005 tablets

Drug

VC005 repeat administration for up to 24 weeks

Primary outcomes

  1. Area Under the Curve From Time Zero to Last Quantifiable Concentration(AUC）

    Time frame: Day1，Day28

  2. Peak Plasma Concentration (Cmax）

    Time frame: Day1，Day28

Interested in participating?

Not yet recruiting

Trial opening soon.

Get Notified

Sponsors and collaborators

Lead sponsor

Jiangsu vcare pharmaceutical technology co., LTD

Industry

Registry information

Official study title

A Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of VC005 Tablets in Adolescent Subjects With Non-Segmental Vitiligo

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Sep 18, 2026
Registry last updated
Sep 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.